939986-86-4

Basic information

• Product Name: 3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27
• Synonyms: 3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27;2-[3-(Hydroxymethyl)-1-piperidinyl]-4-pyridinecarbonitrile;2-(3-(HYDROXYMETHYL)PIPERIDIN-1-YL)ISONICOTINONITRILE
• CAS NO: 939986-86-4
• Molecular Formula: C12H15N3O
• Molecular Weight: 217.267
• Mol File: 939986-86-4.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Density: 1.22
• CAS DataBase Reference: 3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27(CAS DataBase Reference)
• NIST Chemistry Reference: 3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27(939986-86-4)
• EPA Substance Registry System: 3-HydroxyMethyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-4'-carbonitrile, 98+% C12H15N3O, MW: 217.27(939986-86-4)

Safety Data

• Hazardous Substances Data: 939986-86-4(Hazardous Substances Data)

Upstream product

• 4606-65-9 3-(hydroxymethy)piperidine 
• 33252-30-1 2-chloro-4-pyridinenitrile 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF PLATELET AGGREGATION

The present invention provides compounds of Formula I: wherein Y, AA, W, R3, R2, R4, R5, R6, R7, X1, X2, X3, X4 and X5 are as defined herein, or a stereoisomer, tautomer, pharmaceutically acceptable salt, prodrug or esters or solvate form thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of platelet aggregation and thus can be used as medicaments for treating or preventing thromboembolic disorders.